Skip to main content

Verve Therapeutics, Inc.

VERVDelisted Jul 25, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001840574

Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Verve Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Verve Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Verve Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Alphabet Inc.10% Owner0IndirectJul 28, 20250
GV 2017 GP, L.L.C.10% Owner0IndirectJul 28, 20250
GV 2017 GP, L.P.10% Owner0IndirectJul 28, 20250
GV 2017, L.P.10% Owner0IndirectJul 28, 20250
GV 2019 GP, L.L.C.10% Owner0IndirectJul 28, 20250
GV 2019 GP, L.P.10% Owner0IndirectJul 28, 20250
GV 2019, L.P.10% Owner0IndirectJul 28, 20250
GV 2023, L.P.10% Owner0IndirectJul 28, 20250
GV 2023 GP, L.P.10% Owner0IndirectJul 28, 20250
GV 2023 GP, L.L.C.10% Owner0IndirectJul 28, 20250
Adelman Burt ADirector0IndirectJul 28, 20250
MacLean Michael FDirector–Jul 28, 20250
Ashe Andrew D.See Remarks0Jul 28, 20250
Yeshwant KrishnaDirector, 10% Owner0IndirectJul 28, 20250
Coats LonnelDirector–Jul 28, 20250
Morrison Jodie PopeDirector–Jul 28, 20250
Dorval AllisonChief Financial Officer0Jul 28, 20250
Cumbo AlexanderDirector–Jul 28, 20250
Tatsis OuraniaDirector–Jul 28, 20250
Kathiresan SekarChief Executive Officer0IndirectJul 28, 20250
Mikhail SheilaDirector–Jul 28, 20250
Nickerson JoanChief Administrative Officer0Jul 28, 20250
Lister TroyChief Scientific Officer0Jul 28, 20250
Politi JasonChief Technical Ops. Off.0Jul 28, 20250
Fiedorek Fred T.Chief Medical Officer–Feb 16, 20240
Bellinger AndrewChief Scientific Officer42,629Feb 16, 20240
FMR LLCOther: See Remark 1570,729IndirectJul 28, 20220
Evans John M.Director–Jun 13, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 6, 2021 (view filing)Dec 24 daysAdelman Burt ADirectorPPurchase+4.70K$31.34+$147.3KNew position4.70K after
Dec 6, 2021 (view filing)Dec 24 daysAshe Andrew D.See RemarksPPurchase+4.00K$32.10+$128.4K+2.4%170.7K after
Dec 27, 2021 (view filing)Dec 22-235 daysKathiresan SekarChief Executive OfficerSSale−114.0K$39.30−$4.48M−21.9%406.5K after5 lots
Dec 27, 2021 (view filing)Dec 225 daysBellinger AndrewChief Scientific OfficerSSale−15.0K$38.70−$580.4K−75.0%5.00K after3 lots
Dec 29, 2021 (view filing)Dec 27-282 daysKathiresan SekarChief Executive OfficerSSale−48.7K$40.16−$1.96M−10.7%406.5K after4 lots
Jan 6, 2022 (view filing)Jan 42 daysKathiresan SekarChief Executive OfficerSSale−1.87K$39.90−$74.6K−0.5%406.5K after
Jan 28, 2022 (view filing)Jan 26-272 daysFMR LLC10% Owner, Other: See Remark 1SSale−158.8K$31.12−$4.94M−15.3%878.5K after5 lots
Feb 3, 2022 (view filing)Feb 12 daysFMR LLC10% Owner, Other: See Remark 1SSale−35.6K$29.04−$1.03M−4.0%842.9K after
Feb 11, 2022 (view filing)Feb 92 daysFMR LLC10% Owner, Other: See Remark 1SSale−13.2K$29.46−$388.6K−1.6%829.7K after
Mar 11, 2022 (view filing)Mar 92 daysFMR LLC10% Owner, Other: See Remark 1SSale−3.97K$29.01−$115.2K−0.5%825.7K after
Mar 17, 2022 (view filing)Mar 152 daysAdelman Burt ADirectorPPurchase+4.00K$21.38+$85.5K+85.1%8.70K after
May 13, 2022 (view filing)May 121 dayAdelman Burt ADirectorPPurchase+10.0K$12.15+$121.5K+114.9%18.7K after
Jul 1, 2022 (view filing)Jun 29-302 daysFMR LLC10% Owner, Other: See Remark 1SSale−53.2K$15.45−$822.5K−6.4%772.5K after3 lots
Jul 6, 2022 (view filing)Jul 15 daysFMR LLC10% Owner, Other: See Remark 1SSale−38.8K$15.66−$607.2K−4.8%773.7K after
Jul 14, 2022 (view filing)Jul 122 daysFMR LLC10% Owner, Other: See Remark 1SSale−163.0K$20.78−$3.39M−22.2%570.7K after2 lots
Jul 15, 2022 (view filing)Jul 132 daysBellinger AndrewCSO & CMOSSale−10.0K$24.90−$249.0K−60.1%6.63K after
Jul 21, 2022 (view filing)Jul 192 daysKathiresan SekarChief Executive OfficerSSale−50.0K$29.90−$1.50M−13.6%317.8K after
Jul 22, 2022 (view filing)Jul 202 daysBellinger AndrewCSO & CMOSSale−20.0K$34.90−$698.0K−75.1%6.63K after
Aug 11, 2022 (view filing)Aug 101 dayKathiresan SekarChief Executive OfficerSSale−50.0K$29.90−$1.50M−13.6%317.8K after
Sep 27, 2022 (view filing)Sep 234 daysBellinger AndrewCSO & CMOSSale−60.0K$35.34−$2.12M−90.1%6.63K after4 lots
Oct 5, 2022 (view filing)Oct 32 daysKathiresan SekarChief Executive OfficerSSale−50.0K$33.65−$1.68M−13.6%317.8K after3 lots
Nov 1, 2022 (view filing)Oct 284 daysBellinger AndrewCSO & CMOSSale−10.0K$39.90−$399.0K−60.1%6.63K after
Nov 2, 2022 (view filing)Oct 31-Nov 12 daysYeshwant KrishnaDirector, 10% OwnerSSale−85.7K$37.95−$3.25M−1.9%4.39M after7 lots
Nov 2, 2022 (view filing)4:25 PM ETOct 31-Nov 12 daysAlphabet Inc. and 6 othersOther: Member of 10% GroupSSale−171.3K$37.95−$6.50M−3.8%4.39M after14 lots
Nov 4, 2022 (view filing)Nov 2-32 daysYeshwant KrishnaDirector, 10% OwnerSSale−78.2K$33.95−$2.66M−1.8%4.31M after6 lots
Nov 4, 2022 (view filing)4:16 PM ETNov 2-32 daysAlphabet Inc. and 6 othersOther: Member of 10% GroupSSale−156.4K$33.95−$5.31M−3.5%4.31M after12 lots
Nov 8, 2022 (view filing)Nov 44 daysYeshwant KrishnaDirector, 10% OwnerSSale−48.6K$31.14−$1.51M−1.1%4.26M after3 lots
Nov 8, 2022 (view filing)5:04 PM ETNov 44 daysAlphabet Inc. and 6 othersOther: Member of 10% GroupSSale−97.2K$31.14−$3.03M−2.2%4.26M after6 lots
Dec 1, 2022 (view filing)Nov 292 daysDorval AllisonChief Financial OfficerSSale−554$22.10−$12.2K−20.2%2.19K after
Dec 2, 2022 (view filing)Dec 11 dayBellinger AndrewCSO & CMOSSale−865$22.95−$19.9K−11.5%6.63K after
Dec 1, 2023 (view filing)Nov 292 daysDorval AllisonChief Financial OfficerSSale−554$11.45−$6.34K−12.0%4.06K after
Dec 5, 2023 (view filing)Dec 14 daysYeshwant KrishnaDirector, 10% OwnerPPurchase+1.80M$10.00+$18.0MNew position1.80M after
Apr 3, 2024 (view filing)Apr 21 dayNickerson JoanChief Administrative OfficerSSale−1.51K$8.24−$12.5K−14.9%8.66K after10b5-1
May 15, 2024 (view filing)May 141 dayAshe Andrew D.See RemarksPPurchase+76.0K$6.26+$475.8K+28.5%342.5K after
Dec 3, 2024 (view filing)Dec 21 dayDorval AllisonChief Financial OfficerSSale−555$5.64−$3.13K−9.4%5.38K after
Apr 3, 2025 (view filing)Apr 21 dayLister TroyChief Scientific OfficerSSale−2.19K$4.15−$9.08K−23.9%6.95K after10b5-1
Apr 3, 2025 (view filing)Apr 21 dayDorval AllisonChief Financial OfficerSSale−3.35K$4.15−$13.9K−20.1%13.3K after10b5-1
Apr 3, 2025 (view filing)Apr 21 dayPoliti JasonChief Technical Ops. Off.SSale−3.23K$4.15−$13.4K−18.5%14.2K after10b5-1
Apr 3, 2025 (view filing)Apr 21 dayAshe Andrew D.See RemarksSSale−2.68K$4.15−$11.1K−0.8%348.8K after10b5-1
Apr 3, 2025 (view filing)Apr 21 dayNickerson JoanChief Administrative OfficerSSale−2.78K$4.15−$11.5K−13.7%17.4K after10b5-1
Apr 3, 2025 (view filing)Apr 21 dayKathiresan SekarChief Executive OfficerSSale−9.82K$4.15−$40.8K−2.8%346.7K after10b5-1